학술논문
Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2−) breast cancer before chemo-endocrine therapy
Document Type
Article
Author
Du, L.; Yau, C.; Brown-Swigart, L.; Gould, R.; Krings, G.; Hirst, G.L.; Bedrosian, I.; Layman, R.M.; Carter, J.M.; Klein, M.; Venters, S.; Shad, S.; van der Noordaa, M.; Chien, A.J.; Haddad, T.; Isaacs, C.; Pusztai, L.; Albain, K.; Nanda, R.; Tripathy, D.; Liu, M.C.; Boughey, J.; Schwab, R.; Hylton, N.; DeMichele, A.; Perlmutter, J.; Yee, D.; Berry, D.; van't Veer, L.; Valero, V.; Esserman, L.J.; Symmans, W.F.
Source
In Annals of Oncology May 2021 32(5):642-651
Subject
Language
ISSN
0923-7534